Key Dates and Events
- 39th Annual General Meeting: Scheduled for Thursday, September 24, 2026 at 11:30 A.M. (IST) to be conducted through Video Conferencing/Other Audio-Visual Means (VC/OAVM) facility
- Record Date for Final Dividend: Thursday, September 17, 2026 fixed for determining eligibility of members to receive final dividend for financial year 2025-26
- Cut-off Date for E-voting: Thursday, September 17, 2026 fixed for determining eligibility of members to vote electronically on AGM resolutions
- Book Closure Period: Friday, September 18, 2026 to Thursday, September 24, 2026 (both days inclusive)
- E-voting Commencement: Monday, September 21, 2026 at 9:00 A.M.
- E-voting End: Wednesday, September 23, 2026 at 5:00 P.M.
Regulatory and Approval Context
- The Board of Directors approved these dates at their meeting held on August 12, 2026
- The final dividend for FY 2025-26 is subject to approval by members at the ensuing AGM
- The meeting will be conducted in accordance with provisions of the Companies Act, 2013 and rules made thereunder
Financial Impact
The dividend payment represents a cash outflow contingent upon shareholder approval at the AGM. The exact dividend amount per share is not quantified in this disclosure.
Parties Involved
- Stock Exchanges: National Stock Exchange of India Limited (Scrip Code: BALPHARMA) and BSE Limited (Scrip Code: 524824)